Elke Valk

426 total citations
6 papers, 127 citations indexed

About

Elke Valk is a scholar working on Neurology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Elke Valk has authored 6 papers receiving a total of 127 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Neurology, 4 papers in Genetics and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Elke Valk's work include CNS Lymphoma Diagnosis and Treatment (5 papers), Glioma Diagnosis and Treatment (4 papers) and Lymphoma Diagnosis and Treatment (3 papers). Elke Valk is often cited by papers focused on CNS Lymphoma Diagnosis and Treatment (5 papers), Glioma Diagnosis and Treatment (4 papers) and Lymphoma Diagnosis and Treatment (3 papers). Elke Valk collaborates with scholars based in Germany, Switzerland and Netherlands. Elke Valk's co-authors include Jürgen Finke, Benjamin Kasenda, Heidi Fricker, Gerald Illerhaus, Gabriele Ihorst, Kristina Fritsch, Elisabeth Schorb, L. Hollaar, A. van der Laarse and Wim Th. Hermens and has published in prestigious journals such as Blood, Heart and Leukemia.

In The Last Decade

Elke Valk

5 papers receiving 125 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Elke Valk Germany	4	93	92	70	18	13	6	127
Claude‐Fabien Litré France	8	58 0.6×	15 0.2×	32 0.5×	23 1.3×	43 3.3×	14	151
G. Marcacci Italy	4	37 0.4×	56 0.6×	25 0.4×	2 0.1×	8 0.6×	10	90
Hawraman Ramadan United Kingdom	5	39 0.4×	15 0.2×	214 3.1×	11 0.6×	31 2.4×	10	274
Shannon Langmead United States	6	109 1.2×	24 0.3×	11 0.2×	3 0.2×	20 1.5×	11	140
Johann Willeit Austria	4	52 0.6×	24 0.3×	6 0.1×	4 0.2×	28 2.2×	7	90
Marie‐Laure Le Lez France	6	43 0.5×	33 0.4×	11 0.2×	3 0.2×	5 0.4×	23	255
Nadia Younan France	5	36 0.4×	22 0.2×	47 0.7×		9 0.7×	11	88
Mala Varma United States	7	47 0.5×	10 0.1×	29 0.4×	18 1.0×	37 2.8×	13	149
Niaz Islam United Kingdom	9	38 0.4×	45 0.5×	6 0.1×	7 0.4×	28 2.2×	15	243
Y L Cheung China	9	384 4.1×	18 0.2×	12 0.2×	9 0.5×	50 3.8×	13	447

Countries citing papers authored by Elke Valk

Since Specialization

Citations

This map shows the geographic impact of Elke Valk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elke Valk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elke Valk more than expected).

Fields of papers citing papers by Elke Valk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elke Valk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elke Valk. The network helps show where Elke Valk may publish in the future.

Co-authorship network of co-authors of Elke Valk

This figure shows the co-authorship network connecting the top 25 collaborators of Elke Valk. A scholar is included among the top collaborators of Elke Valk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elke Valk. Elke Valk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Wendler, Julia, Richard Lewis, Elke Valk, et al.. (2025). Pre-phase treatment with rituximab and high-dose methotrexate to re-evaluate eligibility for intensive induction treatment of frail patients with central nervous system lymphoma. Haematologica. 110(6). 1384–1388.

2.

Wendler, Julia, Christopher P. Fox, Elke Valk, et al.. (2022). Optimizing MATRix as remission induction in PCNSL: de-escalated induction treatment in newly diagnosed primary CNS lymphoma. BMC Cancer. 22(1). 971–971. 3 indexed citations

3.

Kasenda, Benjamin, Gabriele Ihorst, Roland Schroers, et al.. (2017). High-dose chemotherapy with autologous haematopoietic stem cell support for relapsed or refractory primary CNS lymphoma: a prospective multicentre trial by the German Cooperative PCNSL study group. Leukemia. 31(12). 2623–2629. 56 indexed citations

4.

Schorb, Elisabeth, Jürgen Finke, Andrés J.M. Ferreri, et al.. (2016). High-dose chemotherapy and autologous stem cell transplant compared with conventional chemotherapy for consolidation in newly diagnosed primary CNS lymphoma—a randomized phase III trial (MATRix). BMC Cancer. 16(1). 282–282. 43 indexed citations

5.

Kasenda, Benjamin, Gabriele Ihorst, Heidi Fricker, et al.. (2016). Quality of Life in Patients with Primary CNS Lymphoma - a Pooled Analysis from Three Prospective Multicentre Trials. Blood. 128(22). 5385–5385. 1 indexed citations

6.

Laarse, A. van der, et al.. (1979). Recognition and quantification of myocardial injury by means of plasma enzyme and isoenzyme activities after cardiac surgery.. Heart. 41(6). 660–667. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact